Terms: = Head and neck cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Treatment
171 results:
1. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma.
Hicks RM; Ji X; Zou Y; Sultana S; Rashid R; Sherief ST; Cassoux N; Garcia Leon JL; Diaz Coronado RY; López AMZ; Ushakova TL; Polyakov VG; Roy SR; Ahmad A; Reddy MA; Sagoo MS; Al Harby L; Berry JL; Polski A; Astbury NJ; Bascaran C; Blum S; Bowman R; Burton MJ; Gomel N; Keren-Froim N; Madgar S; Zondervan M; Kaliki S; Fabian ID; Stacey AW
Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):39. PubMed ID: 38662390
[TBL] [Abstract] [Full Text] [Related]
2. Palbociclib inhibits the progression of head and neck cancer and improves the Cetuximab response under specific condition in vitro and in vivo.
Li R; Wang Q; Zhao Y; Zhu Y; Wang X
Mol Biol Rep; 2024 Mar; 51(1):455. PubMed ID: 38536540
[TBL] [Abstract] [Full Text] [Related]
3. Evolutionary trajectories of small cell lung cancer under therapy.
George J; Maas L; Abedpour N; Cartolano M; Kaiser L; Fischer RN; Scheel AH; Weber JP; Hellmich M; Bosco G; Volz C; Mueller C; Dahmen I; John F; Alves CP; Werr L; Panse JP; Kirschner M; Engel-Riedel W; Jürgens J; Stoelben E; Brockmann M; Grau S; Sebastian M; Stratmann JA; Kern J; Hummel HD; Hegedüs B; Schuler M; Plönes T; Aigner C; Elter T; Toepelt K; Ko YD; Kurz S; Grohé C; Serke M; Höpker K; Hagmeyer L; Doerr F; Hekmath K; Strapatsas J; Kambartel KO; Chakupurakal G; Busch A; Bauernfeind FG; Griesinger F; Luers A; Dirks W; Wiewrodt R; Luecke A; Rodermann E; Diel A; Hagen V; Severin K; Ullrich RT; Reinhardt HC; Quaas A; Bogus M; Courts C; Nürnberg P; Becker K; Achter V; Büttner R; Wolf J; Peifer M; Thomas RK
Nature; 2024 Mar; 627(8005):880-889. PubMed ID: 38480884
[TBL] [Abstract] [Full Text] [Related]
4. Comparison of HASTE versus EPI-Based DWI for Retinoblastoma and Correlation with Prognostic Histopathologic Parameters.
Sharma M; Gupta A; Jana M; Kashyap S; Bakhshi S; Sharma S
AJNR Am J Neuroradiol; 2024 Feb; 45(2):198-204. PubMed ID: 38176729
[TBL] [Abstract] [Full Text] [Related]
5. CDK4 phosphorylation status and rational use for combining CDK4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
6. Noncanonical HPV carcinogenesis drives radiosensitization of head and neck tumors.
Schrank TP; Kothari A; Weir WH; Stepp WH; Rehmani H; Liu X; Wang X; Sewell A; Li X; Tasoulas J; Kim S; Yarbrough G; Xie Y; Flamand Y; Marur S; Hayward MC; Wu D; Burtness B; Anderson KS; Baldwin AS; Yarbrough WG; Issaeva N
Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2216532120. PubMed ID: 37523561
[TBL] [Abstract] [Full Text] [Related]
7. Artesunate and cisplatin synergistically inhibit HNSCC cell growth and promote apoptosis with artesunate‑induced decreases in Rb and phosphorylated Rb levels.
Okamoto H; Yoshikawa K; Shimada A; Sano R; Inukai D; Yamanaka S; Suzuki S; Ueda R; Ueda H; Fujimoto Y; Ogawa T
Oncol Rep; 2023 Aug; 50(2):. PubMed ID: 37350399
[TBL] [Abstract] [Full Text] [Related]
8. Diosmetin suppresses the progression of ESCC by CDK2/Rb/E2F2/RRM2 pathway and synergies with cisplatin.
Chen Y; Dai X; Chen W; Qiao Y; Bai R; Duan X; Zhang K; Chen X; Li X; Mo S; Cao W; Li X; Liu K; Dong Z; Lu J
Oncogene; 2023 Jul; 42(29):2278-2293. PubMed ID: 37349644
[TBL] [Abstract] [Full Text] [Related]
9. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract] [Full Text] [Related]
10. CDK4/6 and autophagy inhibitors synergize to suppress the growth of human head and neck squamous cell carcinomas.
Duah E; Seligson ND; Persaud AK; Dam Q; Pabla N; Rocco JW; Li J; Poi M
Mol Carcinog; 2023 Aug; 62(8):1201-1212. PubMed ID: 37132760
[TBL] [Abstract] [Full Text] [Related]
11. Molecular profiling and target actionability for precision medicine in neuroendocrine neoplasms: real-world data.
Boilève A; Faron M; Fodil-Cherif S; Bayle A; Lamartina L; Planchard D; Tselikas L; Kanaan C; Scoazec JY; Ducreux M; Italiano A; Baudin E; Hadoux J
Eur J Cancer; 2023 Jun; 186():122-132. PubMed ID: 37062210
[TBL] [Abstract] [Full Text] [Related]
12. Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors.
Zhang X; Wang Y; Zhang X; Shen Y; Yang K; Ma Q; Qiao Y; Shi J; Wang Y; Xu L; Yang B; Ge G; Hu L; Kong X; Yang C; Chen Y; Ding J; Meng L
Signal Transduct Target Ther; 2023 Apr; 8(1):153. PubMed ID: 37041169
[TBL] [Abstract] [Full Text] [Related]
13. Rocuronium bromide suppresses esophageal cancer via blocking the secretion of C-X-C motif chemokine ligand 12 from cancer associated fibroblasts.
Li J; Gu X; Wan G; Wang Y; Chen K; Chen Q; Lu C
J Transl Med; 2023 Apr; 21(1):248. PubMed ID: 37029408
[TBL] [Abstract] [Full Text] [Related]
14. Combined treatment with
Huang S; Cui M; Wang R; Yang G; Wang N; Cui L; Ma G
Nucleosides Nucleotides Nucleic Acids; 2023; 42(9):731-742. PubMed ID: 36924446
[TBL] [Abstract] [Full Text] [Related]
15. Nutlin-3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation.
Chang WL; Hsieh CH; Kuo IY; Lin CH; Huang YL; Wang YC
Mol Carcinog; 2023 Feb; 62(2):277-287. PubMed ID: 36342355
[TBL] [Abstract] [Full Text] [Related]
16. Human papillomavirus-related neoplasia of the ocular adnexa.
Ramberg IMS
Acta Ophthalmol; 2022 Oct; 100 Suppl 272(Suppl 272):3-33. PubMed ID: 36203222
[TBL] [Abstract] [Full Text] [Related]
17. Risk factors associated with abandonment of care in retinoblastoma: analysis of 692 patients from 10 countries.
Nishath T; Li X; Chandramohan A; Othus M; Ji X; Zou Y; Sultana S; Rashid R; Sherief ST; Cassoux N; Garcia Leon JL; Díaz Coronado R; López AMZ; Ushakova TL; Polyakov VG; Roy SR; Ahmad A; Reddy A; Sagoo MS; Al Harby L; Kim JW; Berry JL; Polski A; Astbury N; Bascaran C; Blum S; Bowman R; Burton MJ; Foster A; Gomel N; Keren-Froim N; Madgar S; Zondervan M; Kaliki S; Fabian ID; Stacey A
Br J Ophthalmol; 2023 Nov; 107(12):1818-1822. PubMed ID: 36113955
[TBL] [Abstract] [Full Text] [Related]
18. Combined TRIP13 and Aurora Kinase Inhibition Induces Apoptosis in Human Papillomavirus-Driven cancers.
Ghosh S; Mazumdar T; Xu W; Powell RT; Stephan C; Shen L; Shah PA; Pickering CR; Myers JN; Wang J; Frederick MJ; Johnson FM
Clin Cancer Res; 2022 Oct; 28(20):4479-4493. PubMed ID: 35972731
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological and mutational analysis of esophageal basaloid squamous cell carcinoma.
Yanai Y; Hayashi T; Tsuyama S; Nasu M; Hashimoto T; Kajiyama Y; Tsurumaru M; Mine S; Orita H; Fukunaga T; Yao T; Saito T
Virchows Arch; 2022 Sep; 481(3):477-487. PubMed ID: 35641667
[TBL] [Abstract] [Full Text] [Related]
20. ZFPM2-AS1: An Oncogenic Long Non-coding RNA in Multiple cancer Types.
Tan F
Mini Rev Med Chem; 2023; 23(1):88-98. PubMed ID: 35578882
[TBL] [Abstract] [Full Text] [Related]
[Next]
